학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 726건 | 목록 1~10
Academic Journal
IEEE Transactions on Magnetics IEEE Trans. Magn. Magnetics, IEEE Transactions on. 30(2):708-710 Mar, 1994
Academic Journal
Rodriguez-Vida A; Medical Oncology Department, Hospital del Mar, CIBERONC, Barcelona.; Valderrama BP; Medical Oncology Department, Hospital Universitario Virgen del Rocío, Sevilla.; Castellano D; Medical Oncology Department, Hospital 12 de Octubre, Madrid.; Pinto A; Medical Oncology Department, Hospital La Paz, Madrid.; Mellado B; Medical Oncology Department, Hospital Clínic, Laboratory of Traslational Genomics in Solid Tumors, IDIBAPS, University of Barcelona, Barcelona.; Puente J; Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), CIBERONC, Madrid.; Climent MA; Medical Oncology Department, Instituto Valenciano de Oncología, Valencia.; Domenech M; Medical Oncology Department, Hospital Althaia, Manresa.; Vazquez F; Medical Oncology Department, Hospital General Universitario de Elche, Alicante.; Perez-Gracia JL; Oncology Department, Clínica Universidad de Navarra, Pamplona.; Bonfill T; Medical Oncology Department, Hospital Universitario Parc Taulí, Sabadell.; Morales-Barrera R; Medical Oncology Department, Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona.; Gonzalez-Billalabeitia E; Medical Oncology Department, Hospital 12 de Octubre, Madrid; Medical Oncology Department, Hospital Morales Meseguer, Murcia.; Garcia-Del-Muro X; Medical Oncology Department, Institut Català d'Oncologia IDIBELL Research Institute, University of Barcelona, Barcelona.; Maroto P; Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona.; Navarro-Gorro N; Medical Oncology Department, Hospital del Mar, CIBERONC, Barcelona.; Juanpere N; Pathology Department, Hospital del Mar, IMIM Research Institute, Barcelona.; Juan O; Medical Oncology, Pivotal S.L.U., Clinical Research Organisation, Madrid, Spain.; Bellmunt J; Medical Oncology Department, Hospital del Mar, CIBERONC, Barcelona; Dana Farber Cancer Center, Harvard Medical School, Boston, USA. Electronic address: Joaquim_Bellmunt@dfci.harvard.edu.
Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE
Academic Journal
Sternberg CN; Englander Institute for Precision Medicine, Weill Cornell Medicine, Meyer Cancer Center, New York, NY, USA; San Camillo and Forlanini Hospitals, Rome, Italy. Electronic address: cns9006@med.cornell.edu.; Loriot Y; Department of Cancer Medicine and INSERM U981, Université Paris-Sud, Université Paris-Saclay, Gustave Roussy, Villejuif, France.; Choy E; CREATE Centre, Section of Rheumatology, Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, UK.; Castellano D; Medical Oncology Service, Hospital Universitario 12 de Octubre, Madrid, Spain.; Lopez-Rios F; Pathology Department, Hospital Universitario 12 de Octubre, Universidad Complutense de Madrid, Research Institute 12 de Octubre University Hospital (i+12), CIBERONC, Madrid, Spain.; Banna GL; Cannizzaro Hospital, Catania, Italy.; Zengerling F; Department of Urology, University Hospital Ulm, Ulm, Germany.; De Giorgi U; IRCCS Istituto Romagnolo per lo Studio dei Tumori Dino Amadori, Meldola, Italy.; Gedye C; Calvary Mater Newcastle, Waratah, Australia.; Masini C; Medical Oncology Unit, Azienda Unita Sanitaria Locale IRCCS Reggio Emilia, Reggio Emilia, Italy.; Bamias A; Alexandra Hospital, National and Kapodistrian University of Athens, Athens, Greece.; Garcia Del Muro X; Institut Catala d'Oncologia, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), University of Barcelona, Barcelona, Spain.; Duran I; Hospital Universitario Virgen del Rocio, Seville, Spain.; Powles T; Barts Cancer Institute, Experimental Cancer Medicine Centre, Queen Mary University of London, St. Bartholomew's Hospital, London, UK.; Retz M; Department of Urology, Technical University of Munich, Rechts der Isar Medical Center, Munich, Germany.; Gamulin M; University Hospital Centre Zagreb and School of Medicine, University of Zagreb, Zagreb, Croatia.; Geczi L; Medical Oncology Center and the National Tumor Biology Laboratory, National Institute of Oncology, Budapest, Hungary.; Huddart RA; Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, UK.; Calabrò F; San Camillo and Forlanini Hospitals, Rome, Italy.; Kandula G; Biostatistics, Hoffmann-La Roche Ltd, Mississauga, Canada.; Skamnioti P; Global Product Development Medical Affairs Oncology, F. Hoffmann-La Roche Ltd, Basel, Switzerland.; Merseburger AS; Department of Urology, Campus Lübeck, University Hospital Schleswig-Holstein, Lübeck, Germany.
Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101665661 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2405-4569 (Electronic) Linking ISSN: 24054569 NLM ISO Abbreviation: Eur Urol Focus Subsets: MEDLINE
Academic Journal
Bührer E; European Organisation for Research and Treatment of Cancer, Brussels, Belgium.; D'Haese D; European Organisation for Research and Treatment of Cancer, Brussels, Belgium.; Daugaard G; Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.; de Wit R; Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Albany C; Horizon Oncology Research, 1345 Unity PI Ste 345, Lafayette, IN, United States of America.; Tryakin A; N.N. Blokhin Russian Cancer Research Center, Moscow, Russian Federation.; Fizazi K; Institut Gustave Roussy, University of Paris Saclay, Villejuif, France.; Stahl O; Department of Oncology, Skåne University Hospital, Lund, Sweden.; Gietema JA; University Medical Centre Groningen, Groningen, the Netherlands.; De Giorgi U; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola, Italy and the Italian Germ Cell Cancer Group (IGG), Italy.; Cafferty FH; Medical Research Council Clinical Trials Unit, University College London (UCL), London, United Kingdom; Institute of Cancer Research Clinical Trials and Statistics Unit, Sutton, United Kingdom.; Hansen AR; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Tandstad T; The Cancer Clinic, St Olavs University Hospital and Department of Clinical and Molecular Medicine, The Norwegian University of Science and Technology, Trondheim, Norway.; Huddart RA; Institute of Cancer Research, Sutton, United Kingdom.; Necchi A; Vita-Salute San Raffaele University, Milan, Italy; Department of Medical Oncology, IRCCS San Raffaele Hospital, Milan, Italy.; Sweeney CJ; South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, Australia.; Garcia-Del-Muro X; Catalan Institute of Oncology, IDIBELL Institute of Research, University of Barcelona, Barcelona, Spain.; Heng DYC; Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta, Canada.; Lorch A; Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland; Department of Urology, University Hospital Dusseldorf, Dusseldorf, Germany.; Chovanec M; 2nd Department of Oncology, Faculty of Medicine, Comenius University and National Cancer Institute, Bratislava, Slovakia; Cancer Research Institute, Biomedical Center, Slovak Academy of Sciences, Bratislava, Slovakia.; Winquist E; Division of Medical Oncology, Western University and London Health Sciences Centre, London, Ontario, Canada.; Grimison P; Australian and New Zealand Urogenital and Prostate Cancer Trials Group, Sydney, Australia.; Feldman DR; Memorial Sloan Kettering Cancer Centre, New York, NY, United States of America; Weill Medical College of Cornell University, New York, NY, United States of America.; Terbuch A; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.; Hentrich M; Department of Hematology and Oncology, Red Cross Hospital, University of Munich, Munich, Germany.; Bokemeyer C; Department of Oncology, Hematology and BMT with Section Pneumology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.; Negaard H; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Fankhauser C; University of Zurich, Zurich, Switzerland.; Shamash J; St Bartholomew's Hospital, London, United Kingdom.; Vaughn DJ; University of Pennsylvania, Philadelphia, PA, United States of America.; Sternberg CN; Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy.; Heidenreich A; Department of Urology, Uro-Oncology, Robot-Assisted and Specialized Urologic Surgery, University Hospital Cologne, Cologne, Germany; Department of Urology, Medical University Vienna, Austria.; Collette L; European Organisation for Research and Treatment of Cancer, Brussels, Belgium.; Gillessen S; Oncology Institute of Southern Switzerland (IOSI), EOC, Bellinzona, Switzerland; Universita della Svizzera Italiana (USI), Lugano, Switzerland.; Beyer J; University Department of Medical Oncology, Inselspital, University Hospital, University of Bern, Bern, Switzerland. Electronic address: joerg.beyer@insel.ch.
Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Garcia del Muro, X.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어